Kirkland & Ellis advised Marlin Equity Partners and its portfolio company Virgin Pulse, a leading global digital-first health, wellbeing and navigation company, in connection with Virgin Pulse’s definitive agreement to merge with HealthComp, a next generation benefits and analytics platform. The merger will create a technology and data powered health platform-as-a-service organization poised to tackle some of the industry’s biggest challenges. The merger is expected to close in Q4 2023, subject to regulatory approvals and satisfaction of all closing conditions under the definitive agreement. Financial details of the transaction have not been disclosed.
The Kirkland team was led by corporate partners John Kaercher, Patrick Salvo, Brendan Caldon and Javier Oliver-Keyworth, with support from partner Marc Browning, and associates Brett Mele, Evan Chavez and Braxton Smith; debt finance partners David Nemecek and Paul Rezvani and associate Elena Babakhanyan; and tax partner Kevin Coenen and associate Michael Alcan.